Gray William K, Day Jamie, Briggs Tim W R, Harrison Simon
Getting It Right First Time programme, NHS England and NHS Improvement, London, UK.
Royal National Orthopaedic Hospital, Stanmore, London, UK.
BJU Int. 2022 Jan;129(1):93-103. doi: 10.1111/bju.15516. Epub 2021 Jul 5.
To investigate volume-outcome relationships in robot-assisted radical prostatectomy (RARP) for cancer using data from the Hospital Episodes Statistics (HES) database for England.
Data for all adult, elective RPs for cancer during the period January 2013-December 2018 (inclusive) were extracted from the HES database. The HES database records data on all National Health Service (NHS) hospital admissions in England. Data were extracted for the NHS trust and surgeon undertaking the procedure, the surgical technique used (laparoscopic, open or robot-assisted), hospital length of stay (LOS), emergency readmissions, and deaths. Multilevel modelling was used to adjust for hierarchy and covariates.
Data were available for 35 629 RPs (27 945 RARPs). The proportion of procedures conducted as RARPs increased from 53.2% in 2013 to 92.6% in 2018. For RARP, there was a significant relationship between 90-day emergency hospital readmission (primary outcome) and trust volume (odds ratio [OR] for volume decrease of 10 procedures: 0.99, 95% confidence interval [CI] 0.99-1.00; P = 0.037) and surgeon volume (OR for volume decrease of 10 procedures: 0.99, 95% CI 0.99-1.00; P = 0.013) in the previous year. From lowest to highest volume category there was a decline in the adjusted proportion of patients readmitted as an emergency at 90 days from 10.6% (0-49 procedures) to 7.0% (≥300 procedures) for trusts and from 9.4% (0-9 procedures) to 8.3% (≥100 procedures) for surgeons. LOS was also significantly associated with surgeon and trust volume, although 1-year mortality was associated with neither.
There is evidence of a volume-outcome relationship for RARP in England and minimising low-volume RARP will improve patient outcomes. Nevertheless, the observed effect size was relatively modest, and stakeholders should be realistic when evaluating the likely impact of further centralisation at a population level.
利用英格兰医院事件统计(HES)数据库的数据,研究机器人辅助根治性前列腺切除术(RARP)治疗癌症时的手术量与治疗结果的关系。
从HES数据库中提取2013年1月至2018年12月(含)期间所有成年癌症患者择期行前列腺切除术(RP)的数据。HES数据库记录了英格兰所有国民健康服务(NHS)医院的入院数据。提取了进行手术的NHS信托机构和外科医生的数据、所采用的手术技术(腹腔镜、开放或机器人辅助)、住院时间(LOS)、急诊再入院情况和死亡情况。采用多水平模型对层次结构和协变量进行调整。
有35629例前列腺切除术(27945例RARP)的数据可用。RARP手术的比例从2013年的53.2%增加到2018年的92.6%。对于RARP,90天急诊再入院(主要结局)与上一年的信托机构手术量(手术量减少10例的比值比[OR]:0.99,95%置信区间[CI]0.99 - 1.00;P = 0.037)和外科医生手术量(手术量减少10例的OR:0.99,95% CI 0.99 - 1.00;P = 0.013)之间存在显著关系。从手术量最低到最高类别,信托机构90天急诊再入院患者的调整比例从10.6%(0 - 49例手术)降至7.0%(≥300例手术),外科医生则从9.4%(0 - 9例手术)降至8.3%(≥100例手术)。住院时间也与外科医生和信托机构手术量显著相关,尽管1年死亡率与两者均无关。
在英格兰,有证据表明RARP存在手术量与治疗结果的关系,尽量减少低手术量的RARP将改善患者预后。然而,观察到的效应大小相对较小,利益相关者在评估进一步集中化在人群层面可能产生的影响时应保持现实态度。